![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 19, 12289-12293, Jul, 1991
ZL Wen, X Tao, F Lakkis, T Kiyokawa and JR Murphy
We have previously reported the genetic construction and properties of a
fusion protein which was composed of the enzymatically active and membrane
translocation domains of the diphtheria toxin and the receptor- specific
ligand alpha-melanocyte-stimulating hormone (alpha-MSH) (Murphy, J.R.,
Bishai, W., Borowski, M., Miyanohara, A., Boyd, J., and Nagle, S. (1986)
Proc. Natl. Acad. Sci. U.S.A. 83, 8258-8262). While this fusion toxin was
found to be selectively toxic for MSH receptor- bearing cells in vitro, it
was subject to profound proteolytic degradation in recombinant Escherichia
coli making purification difficult. We now report that the deletion of
diphtheria toxin fragment B sequences between Thr387 and His485 results in
a protease-resistant form of the fusion toxin, DAB389-alpha-MSH. We show
that DAB389-alpha- MSH is expressed in high yield in recombinant
Escherichia coli, that it is readily purified from crude bacterial lysates
by immunoaffinity and high performance liquid chromatography, and its
cytotoxic activity toward both human and murine malignant melanoma cell
lines is mediated through the MSH receptor.
Diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion toxin. Internal in-frame deletion from Thr387 to His485 results in the formation of a highly potent fusion toxin which is resistant to proteolytic degradation
Evans Department of Clinical Research, University Hospital, Boston University Medical Center, Massachusetts 02118.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I Pastan and D FitzGerald Recombinant toxins for cancer treatment Science, November 22, 1991; 254(5035): 1173 - 1177. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |